(Q36326399)

13 August 2017

1 reference

title

PPAR-gamma agonists and diabetic nephropathy (English)

1 reference

13 August 2017

Yahua Zhang

1

1 reference

13 August 2017

Youfei Guan

series ordinal

2

1 reference

13 August 2017

publication date

1 December 2005

1 reference

13 August 2017

published in

Current diabetes report

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

470-475

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-005-0057-5

13 August 2017

exact match

0 references

cites work

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS11892-005-0057-5

Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-005-0057-5

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-005-0057-5

Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-005-0057-5

Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-005-0057-5

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients

21 January 2018

1 reference

12 December 2020

Anti-inflammatory effect of PPARgamma in cultured human mesangial cells

1 reference

12 December 2020

Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

1 reference

12 December 2020

Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.

1 reference

12 December 2020

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

1 reference

12 December 2020

Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients

1 reference

12 December 2020

Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney

1 reference

12 December 2020

Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

1 reference

12 December 2020

Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits.

1 reference

12 December 2020

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

12 December 2020

Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability

1 reference

12 December 2020

Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists

1 reference

12 December 2020

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

12 December 2020

Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.

1 reference

12 December 2020

PPARs as targets for the modulation of cardiovascular risk factors associated with the metabolic syndrome.

1 reference

12 December 2020

Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats

1 reference

12 December 2020

PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase

1 reference

12 December 2020

PPAR agonists as direct modulators of the vessel wall in cardiovascular disease

1 reference

12 December 2020

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

1 reference

12 December 2020

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

1 reference

12 December 2020

Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity

1 reference

12 December 2020

Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses

1 reference

12 December 2020

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

12 December 2020

Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.

1 reference

12 December 2020

The effect of PPARgamma ligands on the adipose tissue in insulin resistance

1 reference

12 December 2020

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome

1 reference

12 December 2020

Rosiglitazone reduces urinary albumin excretion in type II diabetes

1 reference

12 December 2020

The next generation of diabetic nephropathy therapies: an update

1 reference

12 December 2020

c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinediones

1 reference

12 December 2020

Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats

1 reference

12 December 2020

Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma

1 reference

12 December 2020

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

1 reference

12 December 2020

Pathogenetic mechanisms of diabetic nephropathy

1 reference

12 December 2020

EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation

1 reference

12 December 2020

PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose

1 reference

12 December 2020

The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells

1 reference

12 December 2020

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

12 December 2020

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells

1 reference

12 December 2020

The mode of action of thiazolidinediones

1 reference

12 December 2020

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

1 reference

12 December 2020

PPARs: therapeutic targets for metabolic disease

1 reference

12 December 2020

PPAR ligands: potential therapies for metabolic syndrome

1 reference

12 December 2020

Interdomain communication regulating ligand binding by PPAR-gamma

1 reference

12 December 2020

The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

1 reference

12 December 2020

Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.

1 reference

12 December 2020

Rosiglitazone monotherapy is effective in patients with type 2 diabetes

1 reference

12 December 2020

Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells

1 reference

12 December 2020

The mechanisms of action of PPARs

1 reference

12 December 2020

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

12 December 2020

Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria

1 reference

12 December 2020

10.1007/S11892-005-0057-5

Identifiers

DOI

1 reference

13 August 2017

1 reference